NDC 73441-0800-04

Omidubicel intravenous suspension at Fox Chase Cancer Center

AI-generated description

How this description was generated

Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.

Model: claude-haiku-5-5
Provider: anthropic
API: message_batches
Reasoning effort: low
Max output tokens: 4096
Prompt version (hash): 444523875572
Generated: October 20, 2026

Original text from hospital filings

OMIDUBICEL-ONLV NON-CULTURED FRACTION (NF) IV SUSPENSION (2OF2)

Philadelphia, PA

See all hospitals reporting NDC 73441-0800-04 →

Pricing by billing methodology

Price type

How this price compares nationally

Fox Chase Cancer Center’s median price of $1600.6k is 44% above the median hospital's median price ($1108.4k), higher than 74% of the 31 hospitals reporting NDC 73441-0800-04. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.

Highest hospital$2,752,376
90th percentile$2,141,349
75th percentile$1,583,756
Median$1,108,403
25th percentile$1,022,112
10th percentile$845,575
Lowest hospital$661,128

Last updated: Apr 8, 2026

Compare to other hospitals

See Omidubicel intravenous suspension pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.